Literature DB >> 13123

Neutralization kinetics studies with type SAT2 foot-and-mouth disease virus strains. 1. Factors that influence the rate and pattern of neutralization.

M M Rweyemamu, J C Booth, T W Pay.   

Abstract

A study of the kinetics of inactivation of foot-and-mouth disease virus type SAT 2 strains revealed that in most cases the rate of neutralization was not rectilinear. Deviations from first-order kinetics observed represented biphasic or parabolic and stepwise reactions. The initial rate was rapid and showed no lag phase or shoulder. The effects of deviations from linearity could be minimized by dilution of antiserum to a suitable extent. Treatment of virus-antibody mixtures with anti-species globulin resulted in enhancement of the rate of neutralization of homologous and heterologous reactions without significantly altering the relation between the two. This treatment also considerably reduced the amount of the persistent fraction. In attempt to disaggregate virus it was observed that sodium dodecyl sulphate inhibited neutralization of virus by specific antiserum.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 13123      PMCID: PMC2129742          DOI: 10.1017/s0022172400055984

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  31 in total

1.  Studies on the nature of the nature of the neutralization reaction and the competition for neutralizing antibody between components of the virus system of foot-and-mouth disease.

Authors:  C J BRADISH; J O FARLEY; H E FERRIER
Journal:  Virology       Date:  1962-11       Impact factor: 3.616

2.  ANTIGENIC ANALYSIS OF HERPES SIMPLEX VIRUS BY NEUTRALIZATION KINETICS.

Authors:  W K ASHE; H W SCHERP
Journal:  J Immunol       Date:  1963-11       Impact factor: 5.422

3.  THE INTERACTION BETWEEN VIRUS AND ANTIBODY. I. KINETIC STUDIES.

Authors:  K J LAFFERTY
Journal:  Virology       Date:  1963-09       Impact factor: 3.616

4.  PURIFICATION OF RADIOACTIVE FOOT-AND-MOUTH DISEASE VIRUS.

Authors:  F BROWN; B CARTWRIGHT
Journal:  Nature       Date:  1963-09-21       Impact factor: 49.962

5.  Antigenic characterization of oral poliovaccine progeny by neutralization kinetics.

Authors:  Y OZAKI; A R DIWAN; W D McBRIDE; J L MELNICK
Journal:  J Immunol       Date:  1963-02       Impact factor: 5.422

6.  Kinetic studies on the neutralization reaction between Japanese encephalitis virus and antiserum.

Authors:  N HASHIMOTO; A M PRINCE
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

7.  Reversibility of the reaction between polio-virus and neutralizing antibody of rabbit origin.

Authors:  B MANDEL
Journal:  Virology       Date:  1961-07       Impact factor: 3.616

8.  The neutralisation of the virus of the foot-and-mouth disease by immune serum.

Authors:  P B CAPSTICK; R F SELLERS; C L STEWART
Journal:  Arch Gesamte Virusforsch       Date:  1960

9.  Antigenic analysis of polioviruses by kinetic studies of serum neutralization.

Authors:  W D McBRIDE
Journal:  Virology       Date:  1959-01       Impact factor: 3.616

10.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus.

Authors:  R DULBECCO; M VOGT; A G STRICKLAND
Journal:  Virology       Date:  1956-04       Impact factor: 3.616

View more
  4 in total

1.  Enhancement by diethylamineothyl-dextran of the plaque-forming activity of foot-and-mouth disease virus-antibody complexes in pig kidney IB-RS-2 cells.

Authors:  J C Booth
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Dose-response relationships in a microneutralization test for foot-and-mouth disease viruses.

Authors:  J C Booth; M M Rweyemamu; T W Pay
Journal:  J Hyg (Lond)       Date:  1978-02

3.  Neutralization kinetics studies with type SAT 2 foot-and-mouth disease virus strains.

Authors:  M M Rweyemamu; J C Booth; N Parry; T W Pay
Journal:  J Hyg (Lond)       Date:  1977-06

4.  The application of a single radial haemolysis technique to foot-and-mouth disease virus-antibody study.

Authors:  M M Rweyemamu; N R Parry; J Sargent
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.